The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Abemaciclib for the treatment of brain metastases (BM) secondary to hormone receptor positive (HR+), HER2 negative breast cancer.
 
Sara M. Tolaney
Research Funding - Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Nancy U. Lin
Consulting or Advisory Role - Novartis
Research Funding - Array BioPharma; Genentech; GlaxoSmithKline; Kadmon; Novartis; Oncothyreon
 
Donald Thornton
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Suzanne Klise
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Timothy Michael Costigan
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
P. Kellie Turner
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Carey K. Anders
Consulting or Advisory Role - Angiochem; Genentech/Roche; GERON; Kadmon; Lilly; Merrimack; Nektar; Novartis; Sanofi; to-BBB technologies BV
Research Funding - Angiochem (Inst); Cascadian Therapeutics (Inst); Geron (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); Oncothyreon (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tesaro (Inst); to-BBB technologies BV (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlell; Up to Date.com